Anesthetic Management of Left Ventricular Assist Device Exchange in a Patient with Intracranial Hemorrhage

Anesthesia in LVAD exchange

  • Nevri̇ye Salman Mail Department of Anesthesia and Reanimation, SBU Yüksek İhtisas Ankara Research and Training Hospital, Ankara, Turkey.
  • Sınan Sabıt Kocabeyoğlu Department of Cardiovascular Surgery, SBU Yüksek İhtisas Ankara Research and Training Hospital, Ankara, Turkey.
  • Ülkü Sabuncu Department of Anesthesia and Reanimation, SBU Yüksek İhtisas Ankara Research and Training Hospital, Ankara, Turkey.
  • Ümit Kervan Department of Cardiovascular Surgery, SBU Yuksek Ihtisas Ankara Research and Training Hospital, Ankara, Turkey.
  • Mustafa Paç Department of Cardiovascular Surgery, SBU Yüksek İhtisas Ankara Research and Training Hospital, Ankara, Turkey.
  • Ayşegül Özgök Department of Anesthesia and Reanimation, SBU Yüksek İhtisas Ankara Research and Training Hospital, Ankara, Turkey.
Keywords:
Heart-assist devices, Intracranial hemorrhages, Anesthesia

Abstract

The gold standard treatment for end-stage heart failure is heart transplantation; however, the rate of transplantation remains inadequate because of the paucity of organ donation. The left ventricular assist device (LVAD) has been used as a bridge therapy before transplantation. The LVAD is being used increasingly because it reduces mortality despite the accompanying morbidities. Therefore, the anesthetic management of LVAD-related morbidities is important and requires experience and knowledge. Herein, we describe a 60-year-old male patient with an LVAD with complaints of right hemiparesis, dysphasia, and facial paralysis. We aim to present the anesthetic management of a patient with intracranial hemorrhage who underwent LVAD exchange due to thrombosis.

References

1. Wilson TJ, Stetler WR, Jr, Al-Holou WN, Sullivan SE, Fletcher JJ. Management of intracranial hemorrhage in patients with left ventricular assist devices. J Neurosurg 2013;118:1063-1068.
2. Scandroglio AM, Kaufmann F, Pieri M, Kretzschmar A, Müller M, Pergantis P, Dreysse S, Falk V, Krabatsch T, Potapov EV. Diagnosis and treatment algorithm for blood flow obstructions in patients with left ventricular assist device. J Am Coll Cardiol 2016;67:2758-2768.
3. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-1443.
4. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008;86:1227-1234.
5. Sriganesh K, Venkataramaiah S. Concerns and challenges during anesthetic management of aneurysmal subarachnoid hemorrhage. Saudi J Anaesth 2015;9:306-313.
6. Mets B. Anesthesia for left ventricular assist device placement. J Cardiothorac Vasc Anesth 2000;14:316-326.
7. Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G; European Stroke Organization. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 2013;35:93-112.
Published
2020-01-29
How to Cite
1.
Salman N, Kocabeyoğlu S, Sabuncu Ülkü, Kervan Ümit, Paç M, Özgök A. Anesthetic Management of Left Ventricular Assist Device Exchange in a Patient with Intracranial Hemorrhage. J Tehran Heart Cent. 15(1):31-34.
Section
Case Report(s)